Roy Quiltz
Tuesday, May 8, 2018
Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
Investigators examined the ability to reduce HbA1c over a 2-year period with second-line anti-diabetic agents.
Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
posted first on
https://www.youtube.com/dailyhealthpost/
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment